Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints

Background: Beta lactam group of antibiotics are one among the most widely used against enterobacterales. There has been an escalation of resistance among cephalosporins, and carbapenems in the recent days. Evaluation of resistance rates and careful selection of drugs based on Minimum Inhibitory Con...

Full description

Saved in:
Bibliographic Details
Main Authors: Uma BM, Neelesh Naik, Rama N.K
Format: Article
Language:English
Published: Krishna Vishwa Vidyapeeth (Deemed to be University), Karad 2024-07-01
Series:Journal of Krishna Institute of Medical Sciences University
Subjects:
Online Access:https://www.jkimsu.com/jkimsu-vol13no3/JKIMSU,%20Vol.%2013,%20No.%203,%20July-September%202024%20Page%2060-70.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572536448090112
author Uma BM
Neelesh Naik
Rama N.K
author_facet Uma BM
Neelesh Naik
Rama N.K
author_sort Uma BM
collection DOAJ
description Background: Beta lactam group of antibiotics are one among the most widely used against enterobacterales. There has been an escalation of resistance among cephalosporins, and carbapenems in the recent days. Evaluation of resistance rates and careful selection of drugs based on Minimum Inhibitory Concentration (MIC) aids in effective therapy of infections caused by these resistant strains. Aim and Objectives: To determine the resistance rates of beta lactam antibiotics among enterobacterales, to analyse the relative extent of resistance and susceptibility based on their MIC, relative to their breakpoints, and also to determine MIC 50 and 90. Material and Methods: Study was conducted in a tertiary care hospital in rural Bengaluru from June 2022 to May 2023. A total of 733 clinical isolates from all samples were included in the study. Identification and antimicrobial susceptibility testing was done by VITEK-2 Compact automated system. Results: Based on analysis of MIC among urine samples, resistance rates of 88% for ampicillin, 71% for cefixime and 69% for ceftriaxone was seen. Among other samples 71%,61% and 57% resistance was seen to cefuroxime, ceftriaxone and amoxclav respectively. Least resistance was seen to meropenem (13%) cefoperazone sulbactam (17%) and imipenem (19%). Cefoperazone sulbactam and carbapenems had better susceptibility with MIC 50 less than the susceptible breakpoint. MIC 90 of piperacillin tazobactum and ceftazidime were well above the resistant breakpoint. Conclusion: Understanding the MIC and analysis of susceptibility and resistance of antibiotics will help in rational selection of antibiotics, which may serve as an aid in abating the development of resistant strains. It would be prudent to spare the drugs with MIC 90 above the resistant breakpoint from being included in the empirical panel and should be watchful while using third generation cephalosporins for uncomplicated infections
format Article
id doaj-art-3e5cf29364c545a18a94cae355c0183a
institution Kabale University
issn 2231-4261
language English
publishDate 2024-07-01
publisher Krishna Vishwa Vidyapeeth (Deemed to be University), Karad
record_format Article
series Journal of Krishna Institute of Medical Sciences University
spelling doaj-art-3e5cf29364c545a18a94cae355c0183a2025-02-02T09:11:32ZengKrishna Vishwa Vidyapeeth (Deemed to be University), KaradJournal of Krishna Institute of Medical Sciences University2231-42612024-07-011336070Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpointsUma BM0Neelesh Naik1 Rama N.K2Department of Microbiology, PES University, Institute of Medical Sciences and Research, Bengaluru- 560100 (Karnataka), IndiaDepartment of Microbiology, MVJ Medical College and Research Hospital Bengaluru-562114 (Karnataka) IndiaDepartment of Microbiology, MVJ Medical College and Research Hospital Bengaluru-562114 (Karnataka) IndiaBackground: Beta lactam group of antibiotics are one among the most widely used against enterobacterales. There has been an escalation of resistance among cephalosporins, and carbapenems in the recent days. Evaluation of resistance rates and careful selection of drugs based on Minimum Inhibitory Concentration (MIC) aids in effective therapy of infections caused by these resistant strains. Aim and Objectives: To determine the resistance rates of beta lactam antibiotics among enterobacterales, to analyse the relative extent of resistance and susceptibility based on their MIC, relative to their breakpoints, and also to determine MIC 50 and 90. Material and Methods: Study was conducted in a tertiary care hospital in rural Bengaluru from June 2022 to May 2023. A total of 733 clinical isolates from all samples were included in the study. Identification and antimicrobial susceptibility testing was done by VITEK-2 Compact automated system. Results: Based on analysis of MIC among urine samples, resistance rates of 88% for ampicillin, 71% for cefixime and 69% for ceftriaxone was seen. Among other samples 71%,61% and 57% resistance was seen to cefuroxime, ceftriaxone and amoxclav respectively. Least resistance was seen to meropenem (13%) cefoperazone sulbactam (17%) and imipenem (19%). Cefoperazone sulbactam and carbapenems had better susceptibility with MIC 50 less than the susceptible breakpoint. MIC 90 of piperacillin tazobactum and ceftazidime were well above the resistant breakpoint. Conclusion: Understanding the MIC and analysis of susceptibility and resistance of antibiotics will help in rational selection of antibiotics, which may serve as an aid in abating the development of resistant strains. It would be prudent to spare the drugs with MIC 90 above the resistant breakpoint from being included in the empirical panel and should be watchful while using third generation cephalosporins for uncomplicated infectionshttps://www.jkimsu.com/jkimsu-vol13no3/JKIMSU,%20Vol.%2013,%20No.%203,%20July-September%202024%20Page%2060-70.pdfbeta lactamsenterobacteralesminimum inhibitory concentrationbreakpoint
spellingShingle Uma BM
Neelesh Naik
Rama N.K
Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints
Journal of Krishna Institute of Medical Sciences University
beta lactams
enterobacterales
minimum inhibitory concentration
breakpoint
title Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints
title_full Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints
title_fullStr Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints
title_full_unstemmed Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints
title_short Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints
title_sort evaluation of resistance rates of enterobacterales to beta lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints
topic beta lactams
enterobacterales
minimum inhibitory concentration
breakpoint
url https://www.jkimsu.com/jkimsu-vol13no3/JKIMSU,%20Vol.%2013,%20No.%203,%20July-September%202024%20Page%2060-70.pdf
work_keys_str_mv AT umabm evaluationofresistanceratesofenterobacteralestobetalactamdrugsandinterpretationoftheirminimuminhibitoryconcentrationsrelativetoclinicalbreakpoints
AT neeleshnaik evaluationofresistanceratesofenterobacteralestobetalactamdrugsandinterpretationoftheirminimuminhibitoryconcentrationsrelativetoclinicalbreakpoints
AT ramank evaluationofresistanceratesofenterobacteralestobetalactamdrugsandinterpretationoftheirminimuminhibitoryconcentrationsrelativetoclinicalbreakpoints